2025
-
Gluck Lecturer to Discuss Ongoing Quest for Disease-Modifying Therapies in Osteoarthritis
Osteoarthritis (OA) researcher Richard F. Loeser, Jr., MD, MACR, will explain the fundamental science underlying OA pathogenesis and the potential therapeutic interventions for the disease.
-
Experts to Navigate Shared Pathways of Immune-Gut Axis
A Sunday morning session will delve into the dynamics of how microbial and host byproducts drive inflammation. One of the featured speakers, Renuka Nayak, MD, PhD, will discuss therapeutic approaches to treat rheumatoid arthritis using short-chain fatty acids.
-
Researchers to Detail Benefits of High-Intensity Interval Training for People Living with Rheumatic Conditions
Experts, including Kim M. Huffman, MD, PhD, will highlight how this approach to physical activity affects cardiovascular health, physical function, and immune response.
-
Clinicians to Share Strategies for Branding and Self-Promotion
Speakers, including Diana Girnita, MD, PhD, will share what they have learned about making a private rheumatology practice stand out from the crowd and building trust among patients and prospective patients.
-
Debate to Consider Whether the Current Rheumatology Training Model Meets the Needs of Gen Z
Jennifer Strouse, MD, FACR, and Juliet Aizer, MD, MPH, both experienced instructors, will discuss the impact of generational change on the rheumatology fellowship training environment and strategies to meet the needs of modern learners.
-
Global Summit Keynote Outlines the Impact of Health Technology Assessment in Rheumatology
Sabine Grimm, PhD, MSc, examined how this multidisciplinary process can be harnessed to the benefit of decision-makers, guideline developers, payers, and patients.
-
Two Bootcamp Sessions Will Demystify Rheumatology Statistics and Methodology
On Sunday, speakers will explain how to choose the appropriate statistical analysis for the research question at hand. On Monday, presenters will introduce latent structures and latent variable models.
-
Presenters to Give Update on Progress in CAR-T-Mediated Immune Reset for SLE
Panelists, including Joan Merrill, MD, will discuss data from preliminary studies of chimeric antigen receptor (CAR) T-cell therapy treatment for lupus and review potential future therapies, including autologous CAR-T cells targeting alternative antigens, allogeneic cell therapy treatments, and strategic cell-harnessing treatments.
